Andrew Ruszkiewicz

ORCID: 0000-0001-9052-4948
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Screening and Detection
  • Genetic factors in colorectal cancer
  • Esophageal Cancer Research and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Treatments and Studies
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Surgical Treatments
  • Epigenetics and DNA Methylation
  • Eosinophilic Esophagitis
  • Gastrointestinal disorders and treatments
  • Esophageal and GI Pathology
  • Cancer Cells and Metastasis
  • Cancer-related gene regulation
  • Gastrointestinal Tumor Research and Treatment
  • Neuroendocrine Tumor Research Advances
  • Radiomics and Machine Learning in Medical Imaging
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Eosinophilic Disorders and Syndromes
  • RNA modifications and cancer
  • Lung Cancer Diagnosis and Treatment
  • Gastroesophageal reflux and treatments
  • Liver Disease Diagnosis and Treatment
  • Restraint-Related Deaths
  • Helicobacter pylori-related gastroenterology studies

South Australia Pathology
2015-2024

The University of Adelaide
2013-2024

University of South Australia
2014-2024

Centre for Cancer Biology
2014-2024

Royal Adelaide Hospital
2012-2023

Liechtenstein Institute
2023

Lyell McEwin Hospital
2013-2022

RELX Group (Netherlands)
2019

Chinese University of Hong Kong
2018

Creative Research Enterprises (United States)
2018

Activation of the canonical TGF-β signaling pathway provides growth inhibitory signals in normal intestinal epithelium. Colorectal cancers (CRCs) frequently harbor somatic mutations members TGFBR2 and SMAD4, but to what extent SMAD2 or SMAD3 contribute tumorigenesis is unclear. A cohort 744 primary CRCs 36 CRC cell lines were sequenced for SMAD2, analyzed allelic loss by single-nucleotide polymorphism (SNP) microarray analysis. Mutation spectra compared between genes, pathogenicity was...

10.1158/0008-5472.can-12-2706 article EN Cancer Research 2012-11-09
Claire Vennin Pauline Mélénec Romain Rouet Max Nobis Aurélie Cazet and 95 more Kendelle J. Murphy David Herrmann Daniel A. Reed Morghan C. Lucas Sean Warren Zehra Elgundi Mark Pinese Gabriella Kalna Daniel Roden Monisha Samuel Anaiis Zaratzian Shane T. Grey Andrew Da Silva Wilfred Leung Amber L. Johns Lorraine A. Chantrill Angela Chou Angela Steinmann Mehreen Arshi Tanya Dwarte Danielle Froio Brooke A. Pereira Shona Ritchie Cecilia R Chambers Xanthe Metcalf Nicola Waddell John V. Pearson Ann-Marie Patch Katia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Sean M. Grimmond Oliver Hofmann Angelika N. Christ Timothy J. C. Bruxner Jaswinder S. Samra Nick Pavlakis Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David M. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Caroline Cooper Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Krishna Epari Mo Ballal David Fletcher Sanjay Mukhedkar Nikolajs Zeps Maria Beilin Kynan Feeney Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Rita T. Lawlor Stefania Beghelli Vincenzo Corbo Maria Scardoni Claudio Bassi

Abstract Heterogeneous subtypes of cancer-associated fibroblasts (CAFs) coexist within pancreatic cancer tissues and can both promote restrain disease progression. Here, we interrogate how cells harboring distinct alterations in p53 manipulate CAFs. We reveal the existence a p53-driven hierarchy, where with gain-of-function (GOF) mutant educate dominant population CAFs that establish pro-metastatic environment for GOF null alike. also demonstrate educated by may be reprogrammed either or...

10.1038/s41467-019-10968-6 article EN cc-by Nature Communications 2019-08-12
Jessica L. Chitty Michelle Yam Lara Perryman Amelia L. Parker Joanna N. Skhinas and 95 more Yordanos F. Setargew Ellie T. Y. Mok Emmi Tran Rhiannon D. Grant Sharissa L. Latham Brooke A. Pereira Shona Ritchie Kendelle J. Murphy Michael Trpceski Alison D. Findlay Pauline Mélénec Elysse C. Filipe Audrey Nadalini Sipiththa Velayuthar Gretel Major Kaitlin Wyllie Michael Papanicolaou Shivanjali Ratnaseelan Phoebe A. Phillips George Sharbeen Janet Youkhana Alice G. Russo Antonia Blackwell Jordan F. Hastings Morghan C. Lucas Cecilia R. Chambers Daniel A. Reed Janett Stoehr Claire Vennin Ruth Pidsley Anaiis Zaratzian Andrew M. Da Silva Michael Tayao Brett Charlton David Herrmann Max Nobis Susan J. Clark Andrew V. Biankin Amber L. Johns David R. Croucher Adnan Nagrial Anthony J. Gill Sean M. Grimmond Lorraine A. Chantrill Angela Chou Tanya Dwarte Xanthe L. Metcalf Gloria Jeong Lara Kenyon Nicola Waddell John V. Pearson Ann-Marie Patch Kátia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Amitabha Das Peter H. Cosman Kasim Ismail Alina Stoita David B. Williams Allan Spigellman Duncan McLeo Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine L. Tucker Lesley Andrews Michael Texler Cindy Forrest Mo Ballal David Fletcher Maria Beilin Kynan Feeney Krishna Epari Sanjay Mukhedkar Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen

Abstract The lysyl oxidase family represents a promising target in stromal targeting of solid tumors due to the importance this crosslinking and stabilizing fibrillar collagens its known role tumor desmoplasia. Using small-molecule drug-design approaches, we generated validated PXS-5505, first-in-class highly selective potent pan-lysyl inhibitor. We demonstrate vitro vivo that inhibition decreases chemotherapy-induced pancreatic desmoplasia stiffness, reduces cancer cell invasion metastasis,...

10.1038/s43018-023-00614-y article EN cc-by Nature Cancer 2023-08-28

<h3>AIM</h3> Colorectal cancer has been described in association with hyperplastic polyposis but the mechanism underlying this observation is unknown. The aim of study was to characterise foci dysplasia developing polyps subjects on basis DNA microsatellite status and expression mismatch repair proteins hMLH1, hMSH2, hMSH6. <h3>MATERIALS AND METHODS</h3> material derived from four patients between one six synchronous colorectal cancers. Normal (four), (13), dysplastic malignant (11) samples...

10.1136/gut.47.1.43 article EN Gut 2000-07-01

Abstract Background BRAF is a member of RAF family serine/threonine kinases and mediates cellular responses to growth signals through the RAS-RAF-MAP kinase pathway. Activating mutations in have recently been found about 10% colorectal cancers, with vast majority being V600E hotspot mutation. The aim present study was evaluate clinical, pathological molecular phenotype tumors mutations. Results Mutations were identified 8% (23/275) cancers. They 5–10-fold more frequent infiltrating...

10.1186/1476-4598-5-2 article EN cc-by Molecular Cancer 2006-01-10

Cancer progression is a complex series of events thought to incorporate the reversible developmental process epithelial-to-mesenchymal transition (EMT). In vitro, microRNA-200 family maintains epithelial phenotype by posttranscriptionally inhibiting E-cadherin repressors, ZEB1 and ZEB2. Here, we used in situ hybridization immunohistochemistry assess expression miR-200 EMT biomarkers formalin-fixed paraffin-embedded human colorectal adenocarcinomas. addition, laser capture microdissection...

10.1593/neo.121828 article EN cc-by-nc-nd Neoplasia 2013-02-01

PIK3CA and PTEN mutations are prevalent in colorectal cancer potential markers of response to mitogen-activated protein/extracellular signal-regulated kinase inhibitors anti-EGF receptor antibody therapy. Relationships between phosphoinositide 3-kinase (PI3K) pathway mutation, clinicopathologic characteristics, molecular features, prognosis remain controversial.A total 1,093 stage I-IV cancers were screened for (exons 9 20), KRAS (codons 12-13), BRAF (codon 600) mutations, microsatellite...

10.1158/1078-0432.ccr-12-3614 article EN Clinical Cancer Research 2013-05-01

Background Chimeric antigen receptor (CAR) T cell therapies specific for the CD19 and B-cell maturation have become an approved standard of care worldwide relapsed refractory malignancies. If CAR-T therapy non-hematological malignancies is to achieve same stage clinical development, then iterative early-phase testing can add value development process evaluating products containing different CAR designs manufactured under differing conditions. Methods We conducted a phase 1 trial...

10.1136/jitc-2023-008659 article EN cc-by Journal for ImmunoTherapy of Cancer 2024-05-01

The CpG-island methylator phenotype (CIMP+) in colorectal cancer (CRC) is characterised by frequent hypermethylation of promoter regions tumour suppressor genes. Low level methylation some CpG islands also seen the normal colonic mucosa and increases with age; however, it still unclear what other factors regulate this phenomenon. first aim our study was to determine whether elevated patients CIMP+ tumours. second investigate common, functional polymorphisms genes involved methyl group...

10.1038/sj.bjc.6602940 article EN cc-by-nc-sa British Journal of Cancer 2006-01-17

Abstract This study characterized the contribution of bone marrow-derived cells to human neoplasia and perineoplastic stroma. The Australasian Bone Marrow Transplant Recipient Registry was used identify solid organ that developed in female recipients male allogeneic stem cell transplants. Eighteen suitable cases were identified including several skin cancers, two gastric one rectal adenoma. Light microscopy, fluorescence chromogenic situ hybridization, immunohistochemistry performed...

10.1002/stem.63 article EN Stem Cells 2009-03-12

Summary Hepatocyte clone size was measured in liver samples of 21 patients various stages chronic hepatitis B virus ( HBV ) infection and from to 76 years age. clones containing unique virus–cell DNA junctions formed by the integration were detected using inverse nested PCR . The maximum hepatocyte tended increase with age, although there considerable patient‐to‐patient variation each age group. There an upward trend increasing fibrosis, inflammatory activity seroconversion e‐antigen HB e A...

10.1111/jvh.12380 article EN Journal of Viral Hepatitis 2015-01-26

The most common of all activating BRAF mutations (T1799A) leads to a substitution valine (V) glutamic acid (E) at the position 600 amino sequence. major goal this study was compare detection V600E mutation by DNA sequencing with immunohistochemistry (IHC) using anti-BRAF (VE1) antibody. Archival formalin fixed, paraffin embedded tissues from 352 patients colon adenocarcinoma (n = 279) and papillary thyroid carcinoma 73) were evaluated for IHC. discordant cases re-evaluated repeat IHC,...

10.1097/pat.0000000000000119 article EN cc-by-nc-nd Pathology 2014-07-11

The majority of colorectal cancer (CRC) cases are preventable by early detection and removal precancerous polyps. Even though CRC is the second most common internal in Australia, only 30 per cent population considered to have risk factors participate stool-based test screening programs. Evidence indicates a robust, blood-based, diagnostic assay would increase compliance. A number potential blood-based protein biomarkers for been reported, but all lack sensitivity or specificity use as...

10.1371/journal.pone.0120425 article EN cc-by PLoS ONE 2015-03-20
Vanessa Lakis Rita T. Lawlor Felicity Newell Ann‐Marie Patch Andrea Mafficini and 95 more Anguraj Sadanandam Lambros T. Koufariotis Rebecca L. Johnston Conrad Leonard Scott Wood Borislav C. Rusev Vincenzo Corbo Claudio Luchini Sara Cingarlini Luca Landoni Roberto Salvia Michèle Milella David K. Chang Peter J. Bailey Nigel B. Jamieson Fraser R. Duthie Marie‐Claude Gingras Donna M. Muzny David A. Wheeler Richard A. Gibbs Massimo Milione Lorraine A. Chantrill Paul Timpson Angela Chou Marina Pajic Angela Murphy Tanya Dwarte David Hermann Claire Vennin Thomas R. Cox Brooke A. Pereira Shona Ritchie Daniel A. Reed Cecilia R. Chambers Xanthe L. Metcalf Max Nobis Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Qinying Xu Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David B. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Mo Ballal David Fletcher Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Judith Dixon Maria Scardoni Claudio Bassi Sonia Grimaldi Cinzia Cantù Giada Bonizzato Samantha Bersani

Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups PanNETs, termed T1, T2 T3, distinct patterns methylation. The T1 subgroup was enriched for functional ATRX, DAXX MEN1 wild-type genotypes. contained mutations in recurrent chromosomal losses half genome no association between regions loss levels. were larger had lower MGMT gene body, which showed positive...

10.1038/s42003-020-01469-0 article EN cc-by Communications Biology 2021-02-03

The factors that regulate lymphocyte traffic in chronic hepatitis C (CHC) are not completely defined. Interferon (IFN)-inducible T cell α chemoattractant (I-TAC) is a relatively new member of the CXCR3 chemokine ligand family selectively recruits activated cells to sites inflammation. To determine if I-TAC plays role CHC, we investigated expression virus (HCV)-infected liver biopsy material. messenger RNA (mRNA) levels were significantly increased HCV-infected compared with normal liver,...

10.1002/hep.20167 article EN Hepatology 2004-04-26

Hypermethylation of CpG island loci within gene promoter regions is a frequent event in colorectal cancer that often associated with transcriptional silencing and has been referred to as CIMP+. DNA hypomethylation can occur concert CIMP+, although these two phenomena appear not be related cancer. The authors investigated here whether the methylation level LINE‐1 repeats, surrogate marker for genomic methylation, was cancers matching normal colonic mucosa from 178 patients. MethyLight assay...

10.1111/j.1349-7006.2007.00548.x article EN other-oa Cancer Science 2007-07-19
Coming Soon ...